| PERIOD ENDING | 2-May-09 | 31-Jan-09 | 1-Nov-08 | 2-Aug-08 | | Total Revenue | 521,434 | 512,867 | 791,046 | 842,575 | | Cost of Revenue | 257,630 | 252,732 | 379,137 | 405,913 | | | Gross Profit | 263,804 | 260,135 | 411,909 | 436,662 | | | Operating Expenses | | Research Development | 200,249 | 207,579 | 234,222 | 249,714 | | Selling General and Administrative | 134,142 | 63,872 | 70,027 | 72,823 | | Non Recurring | 8,336 | 9,689 |
-
|
-
| | Others | 30,356 | 48,274 | 34,814 | 34,988 | | | | Total Operating Expenses | 373,083 | 329,414 |
-
|
-
| | | | Operating Income or Loss | (109,279) | (69,279) | 72,846 | 79,137 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (72) | 1,678 | 16,312 | 2,469 | | Earnings Before Interest And Taxes | (109,351) | (67,601) | 89,158 | 81,606 | | Interest Expense | 88 | 2,118 | 3,566 | 5,159 | | Income Before Tax | (109,439) | (69,719) | 85,592 | 76,447 | | Income Tax Expense | 2,018 | (4,709) | 14,646 | 5,080 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (111,457) | (65,010) | 70,946 | 71,367 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (111,457) | (65,010) | 70,946 | 71,367 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($111,457) | ($65,010) | $70,946 | $71,367 |
|
0.33% Nasdaq 
Income Statement
